{
    "clinical_study": {
        "@rank": "70616", 
        "arm_group": {
            "arm_group_label": "Hepatectomy for HCC", 
            "description": "Patients submitted to surgery for HCC"
        }, 
        "brief_summary": {
            "textblock": "Selection criteria for safe hepatectomy for HCC are not well established. The aim of this\n      study was the validation of the selection criteria for safe hepatectomy for hepatocellular\n      carcinoma."
        }, 
        "brief_title": "Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma", 
        "condition": [
            "Hepatectomy", 
            "Hepatecellular Carcinoma", 
            "Cirrhosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Liver Cirrhosis", 
                "Fibrosis", 
                "Carcinoma, Hepatocellular"
            ]
        }, 
        "detailed_description": {
            "textblock": "All consecutive patients submitted to hepatectomy for HCC based on the same preoperative\n      selection criteria from our prospectively-maintained liver unit database. Such criteria\n      included the value of bilirubin (BIL), the value of cholinesterases (CHE), the presence of\n      ascites, the presence of esophageal varices, and the rate of residual liver volume."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  any patient with HCC submitted to hepatic resection at our Unit in the established\n             frame time\n\n        Exclusion Criteria:\n\n          -  any patient with missing data or lost at follow-up"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The records of 336 consecutive patients who were submitted to hepatectomy between\n        2004-2012 were reviewed."
            }
        }, 
        "enrollment": {
            "#text": "336", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02056041", 
            "org_study_id": "SafeSurgeryHCC"
        }, 
        "intervention": {
            "arm_group_label": "Hepatectomy for HCC", 
            "intervention_name": "Hepatectomy", 
            "intervention_type": "Procedure", 
            "other_name": [
                "Liver surgery", 
                "Liver resection", 
                "Hepatic resection"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rozzano, Milan", 
                    "country": "Italy", 
                    "zip": "20089"
                }, 
                "name": "Humanitas Research Hospital"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma: Validation on 336 Consecutive Hepatectomies.", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary endpoint was the validation of our selection criteria for safe hepatectomy for HCC in regards to postoperative complications. The role of total bilirubin and cholinesterases was analzyed together with other clinical parameters.", 
            "measure": "Safety of surgery for HCC", 
            "safety_issue": "No", 
            "time_frame": "90 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02056041"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Milan", 
            "investigator_full_name": "Prof. Guido Torzilli", 
            "investigator_title": "Professor of Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The secondary endpoint was the testing of the most common score systems for HCC, which are the CPT score, the MELD score, and the APRI score.", 
            "measure": "Score systems HCC", 
            "safety_issue": "No", 
            "time_frame": "90 days"
        }, 
        "source": "University of Milan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Milan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2004", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "90 Days", 
        "verification_date": "February 2014"
    }
}